Green Thumb Industries Inc. (GTBIF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Bio-Rad's (BIO) margin performance gets affected by the inflationary trend of elevated raw material costs, increased logistics costs and higher employee-related expenses.
Bio-Rad Laboratories Inc (NYSE:BIO), a global leader in the life science research and clinical diagnostic markets, provides a wide range of products and services for the healthcare industry.